Product Overview
DCA Vantage AnalyzerDrive diabetic patient compliance with trusted, clinically proven results
The DCA Vantage® Analyzer is a multi-parameter, point-of-care analyzer for monitoring glycemic control in patients with diabetes and detecting early kidney disease.
- CLIA-waived HbA1c test that is IFCC and NGSP-certified
- 1µl finger stick without fasting – HbA1c results in 6 minutes
- Random urine sample provides A:C ratio in 7 minutes
- Requires no sample or reagent preparation prior to testing
Features & Benefits
Easy to use and implement
- Plug and play installation
- Simple, one-step calibration scan with every new lot
- Guided user-interface with step-by-step testing instructions
- Hassle-free maintenance
Improve patient outcomes and operational costs
- Increase patient satisfaction when testing during office visit1
- Aid in lowering HbA1c levels over time2,3
- Reduce costs associated with post-visit testing1
- Satisfy HbA1c and kidney check HEDIS quality measures
Failsafe measures for audit risk mitigation
- QC lockout prevents patient testing if QC not tested or fails
- Prevent unauthorized users from testing and accessing confidential patient information
- Eliminate transcription errors with bar-code data entry and automatic transmission of results
- Link patient results to operators and material lot information (audit-ready)
- Customizable operator-specific system access mode
Results you can trust
- Robust reagent cartridges designed to minimize pre-analytical errors associated with sample and reagent handling
- Consistently meet NGSP and IFCC annual certifications for HbA1c
- Clinically proven to correlate with lab methods4,5
